Mike A. Clark

3.4k total citations
58 papers, 2.7k citations indexed

About

Mike A. Clark is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Mike A. Clark has authored 58 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 15 papers in Physiology and 10 papers in Genetics. Recurrent topics in Mike A. Clark's work include Receptor Mechanisms and Signaling (9 papers), Cancer Research and Treatments (8 papers) and Asthma and respiratory diseases (8 papers). Mike A. Clark is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Cancer Research and Treatments (8 papers) and Asthma and respiratory diseases (8 papers). Mike A. Clark collaborates with scholars based in United States, United Kingdom and India. Mike A. Clark's co-authors include John S. Bomalaski, Frederick W. Holtsberg, Mark Ensor, Jerry W. Shay, Stanley T. Crooke, Steven A. Curley, Seymour Mong, Marion R. Steiner, Robert Shorr and Víctor G. Prieto and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Mike A. Clark

57 papers receiving 2.6k citations

Peers

Mike A. Clark
Vicente Notario United States
Ji Young Yoo United States
Youngkyu Park South Korea
Esper Boel Denmark
Jason R. Cantor United States
Burton M. Wice United States
Vicente Notario United States
Mike A. Clark
Citations per year, relative to Mike A. Clark Mike A. Clark (= 1×) peers Vicente Notario

Countries citing papers authored by Mike A. Clark

Since Specialization
Citations

This map shows the geographic impact of Mike A. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike A. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike A. Clark more than expected).

Fields of papers citing papers by Mike A. Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike A. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike A. Clark. The network helps show where Mike A. Clark may publish in the future.

Co-authorship network of co-authors of Mike A. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Mike A. Clark. A scholar is included among the top collaborators of Mike A. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike A. Clark. Mike A. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clark, Mike A., Lisa K. Gilliland, & Herman Waldmann. (2015). Hybrid Antibodies for Therapy. Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy. 31–49.
2.
Izzo, Francesco, Maurizio Montella, Guglielmo Nasti, et al.. (2006). Pegylated arginine deiminase lowers hepatitis C viral titers and inhibits nitric oxide synthesis. Journal of Gastroenterology and Hepatology. 22(1). 86–91. 32 indexed citations
3.
Bomalaski, John S. & Mike A. Clark. (2004). Serum uric acid-lowering therapies: Where are we heading in management of hyperuricemia and the potential role of uricase. Current Rheumatology Reports. 6(3). 240–247. 65 indexed citations
4.
Prieto, Víctor G., Steven A. Curley, Mark Ensor, et al.. (2004). Incidence and distribution of argininosuccinate synthetase deficiency in human cancers. Cancer. 100(4). 826–833. 242 indexed citations
5.
Izzo, Francesco, Paolo Marra, Gerardo Beneduce, et al.. (2004). Pegylated Arginine Deiminase Treatment of Patients With Unresectable Hepatocellular Carcinoma: Results From Phase I/II Studies. Journal of Clinical Oncology. 22(10). 1815–1822. 199 indexed citations
7.
Goodnough, Michael C., George A. Oyler, Paul S. Fishman, et al.. (2002). Development of a delivery vehicle for intracellular transport of botulinum neurotoxin antagonists1. FEBS Letters. 513(2-3). 163–168. 29 indexed citations
8.
Goddard, David H., John S. Bomalaski, Stanley Lipper, Robert Shorr, & Mike A. Clark. (1996). Phospholipase A2-mediated inflammation induces regression of malignant gliomas. Cancer Letters. 102(1-2). 1–6. 14 indexed citations
9.
Guthridge, Carla, Martha R. Stampfer, Mike A. Clark, & Marion R. Steiner. (1994). Phospholipases A2 in ras-transformed and immortalized human mammary epithelial cells. Cancer Letters. 86(1). 11–21. 23 indexed citations
10.
Clark, Mike A., et al.. (1993). Guanine nucleotides and pertussis toxin reduce the affinity of histamine H3 receptors on AtT-20 cells. Inflammation Research. 40(3-4). 129–134. 19 indexed citations
11.
Bomalaski, John S. & Mike A. Clark. (1993). Phospholipase A2 and arthritis. Arthritis & Rheumatism. 36(2). 190–198. 76 indexed citations
12.
Siegel, Marvín I., et al.. (1992). Characterization of a Digitonin‐Solubilized Bovine Brain H3 Histamine Receptor Coupled to a Guanine Nucleotide‐Binding Protein. Journal of Neurochemistry. 59(5). 1661–1666. 18 indexed citations
13.
Clark, Mike A., et al.. (1992). Quantitative autoradiography of 3H-paroxetine binding sites in rat brain. Journal of Pharmacological and Toxicological Methods. 27(4). 209–216. 42 indexed citations
15.
Clark, Mike A., et al.. (1992). High affinity histamine H3 receptors regulate ACTH release by AtT-20 cells. European Journal of Pharmacology. 210(1). 31–35. 17 indexed citations
16.
Ozgur, Lynne, et al.. (1992). Isolation and characterization of three lysophospholipases from the murine macrophage cell line WEHI 265.1. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1165(2). 229–238. 19 indexed citations
17.
Shih, Neng‐Yang, et al.. (1990). Characterization and tissue distribution of H3 histamine receptors in guinea pigs by Nα-methylhistamine. Biochemical and Biophysical Research Communications. 168(3). 979–986. 73 indexed citations
18.
Strohsacker, Mark W., Michael D. Minnich, Mike A. Clark, Robert Shorr, & Stanley T. Crooke. (1988). Selective purification of cardiac myosin by a high-performance salicylate affinity column. Journal of Chromatography A. 435(1). 185–192. 8 indexed citations
19.
Holskin, Beverly P., James E. Strickler, Joselina Gorniak, et al.. (1987). Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF. Nature. 330(6148). 581–583. 119 indexed citations
20.
Bomalaski, John S., Mike A. Clark, & Robert B. Zurier. (1986). Enhanced phospholipase activity in peripheral blood monocytes from patients with rheumatoid arthritis. Arthritis & Rheumatism. 29(3). 312–318. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026